vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Vital Farms, Inc. (VITL). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $213.6M, roughly 1.7× Vital Farms, Inc.). Vital Farms, Inc. runs the higher net margin — 7.6% vs -0.8%, a 8.4% gap on every dollar of revenue. On growth, Vital Farms, Inc. posted the faster year-over-year revenue change (28.7% vs 9.4%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $-32.1M). Over the past eight quarters, Vital Farms, Inc.'s revenue compounded faster (20.2% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Vital Tomosi Dairy Limited is a dairy processing company in Uganda. The company is a joint venture between Vital Capital Fund, "an impact investing fund primarily focused on Sub-Saharan Africa", and "Tomosi Dairy Farms, a Ugandan producer of dairy products".
ASIX vs VITL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $213.6M |
| Net Profit | $-2.8M | $16.3M |
| Gross Margin | 7.6% | 35.8% |
| Operating Margin | -0.7% | 10.0% |
| Net Margin | -0.8% | 7.6% |
| Revenue YoY | 9.4% | 28.7% |
| Net Profit YoY | -892.9% | 54.3% |
| EPS (diluted) | $-0.11 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $213.6M | ||
| Q3 25 | $374.5M | $198.9M | ||
| Q2 25 | $410.0M | $184.8M | ||
| Q1 25 | $377.8M | $162.2M | ||
| Q4 24 | $329.1M | $166.0M | ||
| Q3 24 | $398.2M | $145.0M | ||
| Q2 24 | $453.5M | $147.4M | ||
| Q1 24 | $336.8M | $147.9M |
| Q4 25 | $-2.8M | $16.3M | ||
| Q3 25 | $-2.6M | $16.4M | ||
| Q2 25 | $31.4M | $16.6M | ||
| Q1 25 | $23.3M | $16.9M | ||
| Q4 24 | $352.0K | $10.6M | ||
| Q3 24 | $22.3M | $7.4M | ||
| Q2 24 | $38.9M | $16.3M | ||
| Q1 24 | $-17.4M | $19.0M |
| Q4 25 | 7.6% | 35.8% | ||
| Q3 25 | 6.8% | 37.7% | ||
| Q2 25 | 14.3% | 38.9% | ||
| Q1 25 | 14.2% | 38.5% | ||
| Q4 24 | 3.4% | 36.1% | ||
| Q3 24 | 14.4% | 36.9% | ||
| Q2 24 | 17.9% | 39.1% | ||
| Q1 24 | 0.9% | 39.8% |
| Q4 25 | -0.7% | 10.0% | ||
| Q3 25 | -0.9% | 10.8% | ||
| Q2 25 | 7.7% | 12.9% | ||
| Q1 25 | 7.7% | 13.4% | ||
| Q4 24 | -3.9% | 7.8% | ||
| Q3 24 | 7.5% | 6.4% | ||
| Q2 24 | 11.5% | 11.6% | ||
| Q1 24 | -7.0% | 16.3% |
| Q4 25 | -0.8% | 7.6% | ||
| Q3 25 | -0.7% | 8.3% | ||
| Q2 25 | 7.7% | 9.0% | ||
| Q1 25 | 6.2% | 10.4% | ||
| Q4 24 | 0.1% | 6.4% | ||
| Q3 24 | 5.6% | 5.1% | ||
| Q2 24 | 8.6% | 11.1% | ||
| Q1 24 | -5.2% | 12.9% |
| Q4 25 | $-0.11 | $0.35 | ||
| Q3 25 | $-0.10 | $0.36 | ||
| Q2 25 | $1.15 | $0.36 | ||
| Q1 25 | $0.86 | $0.37 | ||
| Q4 24 | $0.02 | $0.23 | ||
| Q3 24 | $0.82 | $0.16 | ||
| Q2 24 | $1.43 | $0.36 | ||
| Q1 24 | $-0.65 | $0.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $48.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $351.3M |
| Total Assets | $1.7B | $518.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $48.8M | ||
| Q3 25 | $23.7M | $93.8M | ||
| Q2 25 | $18.4M | $108.2M | ||
| Q1 25 | $8.3M | $156.3M | ||
| Q4 24 | $19.6M | $150.6M | ||
| Q3 24 | $17.3M | $149.5M | ||
| Q2 24 | $12.1M | $133.2M | ||
| Q1 24 | $20.6M | $113.8M |
| Q4 25 | $815.2M | $351.3M | ||
| Q3 25 | $818.2M | $331.2M | ||
| Q2 25 | $823.7M | $309.8M | ||
| Q1 25 | $794.4M | $288.9M | ||
| Q4 24 | $774.6M | $269.3M | ||
| Q3 24 | $766.4M | $253.4M | ||
| Q2 24 | $746.6M | $238.4M | ||
| Q1 24 | $713.2M | $213.3M |
| Q4 25 | $1.7B | $518.7M | ||
| Q3 25 | $1.7B | $481.5M | ||
| Q2 25 | $1.6B | $430.8M | ||
| Q1 25 | $1.6B | $376.9M | ||
| Q4 24 | $1.6B | $359.3M | ||
| Q3 24 | $1.5B | $344.7M | ||
| Q2 24 | $1.5B | $320.5M | ||
| Q1 24 | $1.5B | $300.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $5.8M |
| Free Cash FlowOCF − Capex | $36.1M | $-32.1M |
| FCF MarginFCF / Revenue | 10.0% | -15.1% |
| Capex IntensityCapex / Revenue | 7.7% | 17.8% |
| Cash ConversionOCF / Net Profit | — | 0.35× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $-48.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $5.8M | ||
| Q3 25 | $26.6M | $23.4M | ||
| Q2 25 | $21.1M | $-761.0K | ||
| Q1 25 | $11.4M | $5.3M | ||
| Q4 24 | $64.2M | $14.8M | ||
| Q3 24 | $57.3M | $10.0M | ||
| Q2 24 | $50.2M | $16.1M | ||
| Q1 24 | $-36.2M | $23.9M |
| Q4 25 | $36.1M | $-32.1M | ||
| Q3 25 | $66.0K | $-10.6M | ||
| Q2 25 | $-7.2M | $-7.6M | ||
| Q1 25 | $-22.6M | $2.1M | ||
| Q4 24 | $29.8M | $-3.4M | ||
| Q3 24 | $26.8M | $6.4M | ||
| Q2 24 | $16.7M | $10.5M | ||
| Q1 24 | $-71.6M | $22.6M |
| Q4 25 | 10.0% | -15.1% | ||
| Q3 25 | 0.0% | -5.3% | ||
| Q2 25 | -1.7% | -4.1% | ||
| Q1 25 | -6.0% | 1.3% | ||
| Q4 24 | 9.1% | -2.0% | ||
| Q3 24 | 6.7% | 4.4% | ||
| Q2 24 | 3.7% | 7.2% | ||
| Q1 24 | -21.3% | 15.3% |
| Q4 25 | 7.7% | 17.8% | ||
| Q3 25 | 7.1% | 17.1% | ||
| Q2 25 | 6.9% | 3.7% | ||
| Q1 25 | 9.0% | 1.9% | ||
| Q4 24 | 10.4% | 10.9% | ||
| Q3 24 | 7.7% | 2.5% | ||
| Q2 24 | 7.4% | 3.8% | ||
| Q1 24 | 10.5% | 0.9% |
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | 0.67× | -0.05× | ||
| Q1 25 | 0.49× | 0.31× | ||
| Q4 24 | 182.29× | 1.40× | ||
| Q3 24 | 2.57× | 1.34× | ||
| Q2 24 | 1.29× | 0.99× | ||
| Q1 24 | — | 1.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
VITL
| Eggs And Egg Related Products | $205.8M | 96% |
| Butter And Butter Related Products | $7.7M | 4% |
